✦ LIBER ✦

Combination of topotecan with cytarabine or etoposide in patients with refractory or relapsed acute myeloid leukemia: Results of a randomized phase I/II study

✍ Scribed by Norbert Vey; Hagop Kantarjian; Miloslav Beran; Susan O'Brien; Jorge Cortes; Charles Koller; Elihu Estey

Book ID: 110233743
Publisher: Springer US
Year: 1999
Tongue: English
Weight: 67 KB
Volume: 17
Category: Article
ISSN: 0167-6997
DOI: 10.1023/a:1006271618635

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pilot study of Mylotarg, idarubicin and

Pilot study of Mylotarg, idarubicin and cytarabine combination regimen in patients with primary resistant or relapsed acute myeloid leukemia

✍ Yesid Alvarado; Apostolia Tsimberidou; Hagop Kantarjian; Jorge Cortes; Guillermo 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 168 KB

Mitoxantrone, etoposide, and cytarabine

Mitoxantrone, etoposide, and cytarabine plus cyclosporine for patients with relapsed or refractory acute myeloid leukemia : An Eastern Cooperative Oncology Group pilot study

✍ Martin S. Tallman; Sandra Lee; Branimir I. Sikic; Elisabeth Paietta; Peter H. Wi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## Background: One potential mechanism of drug resistance to chemotherapy is the overexpression of multidrug resistance (mdr) genes coding for p-glycoprotein (p-gp), which leads to reduced intracellular retention of chemotherapy. this study tested the efficacy and toxicity of mitoxantrone, etoposid

Phase 2 randomized study of p53 antisens

Phase 2 randomized study of p53 antisense oligonucleotide (cenersen) plus idarubicin with or without cytarabine in refractory and relapsed acute myeloid leukemia

✍ Jorge Cortes; Hagop Kantarjian; Edward D. Ball; John DiPersio; Jonathan E. Kolit 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB

Single-dose mitoxantrone in combination

Single-dose mitoxantrone in combination with continuous infusion intermediate-dose cytarabine plus etoposide for treatment of refractory or early relapsed acute myeloid leukemia

✍ Sung-Sook Lee; Je-Hwan Lee; Jung-Hee Lee; Dae-Young Kim; Se Hyung Kim; Sung-nam 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Results of a phase 2 study of valproic a

Results of a phase 2 study of valproic acid alone or in combination with all-transretinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia

✍ Andrea Kuendgen; Sabine Knipp; Frank Fox; Corinna Strupp; Barbara Hildebrandt; C 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 97 KB

A phase I/II study of the MDR modulator

A phase I/II study of the MDR modulator Valspodar (PSC 833) combined with daunorubicin and cytarabine in patients with relapsed and primary refractory acute myeloid leukemia

✍ Astrid Gruber; Magnus Björkholm; Lorentz Brinch; Stein Evensen; Bengt Gustavsson 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 70 KB